What is the comparison between Tamsulosin (Flomax) and Silodosin (Rapaflo)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tamsulosin (Flomax) and Silodosin (Rapaflo) Comparison Tamsulosin (Flomax) and Silodosin (Rapaflo) are both alpha-blockers used to treat benign prostatic hyperplasia (BPH) symptoms, with Rapaflo being a better option for patients with severe BPH symptoms due to its higher selectivity for the alpha-1A receptor subtype [@32@].

  • Key differences:
    • Flomax has a longer history of use and a more established safety profile, making it a first-line treatment option.
    • Rapaflo has a higher selectivity for the alpha-1A receptor subtype, which may provide better efficacy for severe BPH symptoms.
  • Dosage and Administration:
    • The typical dose of Flomax is 0.4mg once daily.
    • Rapaflo is usually prescribed at 8mg once daily.
  • Important Considerations:
    • Patients should consult a healthcare provider to determine the most suitable medication and dosage for their individual condition, medical history, and potential interactions with other medications.
    • Patients should be cautious when starting either medication, as they can cause orthostatic hypotension, and it's recommended to take the first dose at bedtime to minimize this risk.
    • Patients should be monitored for any changes in their condition or the development of adverse effects, such as dizziness, lightheadedness, or ejaculatory dysfunction, which are more common with alpha-blockers [1, @32@].

From the FDA Drug Label

Tamsulosin hydrochloride is extensively bound to human plasma proteins (94% to 99%), primarily alpha1 acid glycoprotein (AAG), with linear binding over a wide concentration range (20 to 600 ng/mL) Silodosin is a selective antagonist of alpha-1 adrenoreceptors.

The FDA drug label does not answer the question.

From the Research

Comparison of Tamsulosin (Flomax) and Silodosin (Rapaflo)

  • Both Tamsulosin and Silodosin are alpha-blockers used to treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) 2, 3, 4, 5.
  • Studies have shown that Silodosin may have a more significant improvement in urologic symptom scores compared to Tamsulosin 3, 4.
  • However, Silodosin is likely to increase sexual adverse events, such as ejaculatory dysfunction, compared to Tamsulosin 3, 4, 5.
  • Tamsulosin and Silodosin have similar efficacy in improving quality of life, but Silodosin may have a higher rate of sexual side effects 4, 5.
  • Both medications are generally well-tolerated, but Silodosin may cause more retrograde ejaculation, while Tamsulosin may cause more postural hypotension 5.

Efficacy Comparison

  • A study found that Silodosin significantly improved the International Prostate Symptom Score (IPSS) total score compared to Tamsulosin in the first treatment period 3.
  • Another study found that Silodosin may result in little to no difference in urologic symptom scores compared to Tamsulosin, but may increase sexual adverse events 4.
  • A randomized controlled trial found that Silodosin and Tamsulosin had similar efficacy in reducing IPSS, but Silodosin had a significant impact on sexual function 5.

Safety Comparison

  • Silodosin is likely to increase sexual adverse events, such as ejaculatory dysfunction, compared to Tamsulosin 3, 4, 5.
  • Tamsulosin may cause more postural hypotension compared to Silodosin 5.
  • Both medications are generally well-tolerated, but patients should be monitored for potential side effects 2, 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.